In Brief: Saliva Diagnostic Systems
This article was originally published in The Gray Sheet
Saliva Diagnostic Systems: Plans to roll out its Hema Strip HIV-1/2 test kit in international markets in mid-February following production ramp-up. The finger-stick test, which will be sold to distributors for $2-3 each, takes "only a few minutes" and "requires no special training or additional equipment," according to the company. Initial sales of the qualitative test will be in India via the Fremont Group and in China "through local representatives." Studies show the test is "over 99.5% accurate," SDS states...
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.